Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 147-152 , 2009

Resistance pattern of breakthrough urinary tract infections in children on antibiotic prophylaxis

  • Ali Reza Nateghian

      Affiliations

    • Pediatric Infectious Diseases Department, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran
    • ,
  • Joan L. Robinson

      Affiliations

    • Department of Pediatrics and Stollery Children's Hospital, University of Alberta, Edmonton, Canada
    • Corresponding Author InformationCorresponding author at: Room 8213, Aberhart Centre One, 11402 University Avenue, Edmonton, AB, Canada T6G 2J3. Tel.: +1 780 407 3666; fax: +1 780 407 7136.
    • ,
  • Shahab Mohandessi

      Affiliations

    • Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran
    • ,
  • Nakysa Hooman

      Affiliations

    • Pediatric Nephrology Department, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran

Received 27 May 2009 ,Revised 7 August 2009 ,Accepted 11 August 2009.

References 

  1. Nuutinen M, Uhari M. Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol. 2001;16:69–72
  2. Brumfitt W, Hamilton-Miller JM. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection. 1995;23:98–102
  3. Lettgen B, Tröster K. Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin. Clin Padiatr. 2002;214:353–358
  4. Seracini D, Materassi M, Danti A. Non-comparative open study of the efficacy and tolerance of cefaclor in the prevention of urinary tract infections in children. Pediatr Med Chir. 1996;18:383–385
  5. Stranieri G, Zampogna S, Ielapi V, Defilippo RG, Defilippo V, Cristofaro G, et al. Cefixime for the prophylaxis of urinary tract infections in children with malformative uropathies: an open study. Eur Rev Med Pharmacol Sci. 2003;7:57–64
  6. Yokota T. Prophylactic effect of small doses of antibiotics for the prevention of recurrent urinary tract infections. Jpn Pediatr Soc. 1992;96:984–993
  7. Roussey-Kesler G, Gadjos V, Idres N, Grellier A, Hazart L, De parscau , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179:674–679
  8. Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, et al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents. 2006;28:413–416
  9. Mori R, Lakhanpaul M, Verrier-Jones K. Guidelines. Diagnosis and management of urinary tract infection in children: summary of NICE guidance. BMJ. 2007;335:395–397
  10. Hajibagheri K, Priesemann M, Morrison I, Parikh A, Lessof N, Price E. NICE guidance on urinary tract infection in children abandons routine antibiotic prophylaxis. Arch Dis Child. 2008;93:356
  11. Cheng C, Tsai M, Huang Y, Su L, Tsau Y, Lin C, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics. 2008;122:1212–1217
  12. Williams GJ, Wei L, Lee A, Craig JC. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev. 2006;3:CD001534

PII: S1876-0341(09)00057-4

doi: 10.1016/j.jiph.2009.08.002

Journal of Infection and Public Health
Volume 2, Issue 3 , Pages 147-152 , 2009

Article Tools

* Image Usage & Resolution